Divis Laboratories Ltd share price logo

Divis Laboratories Ltd

NSE: DIVISLAB

BSE: 532488

Large Cap

Pharma Sector

6533.00

-20.50

(-0.31%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Divis Laboratories Stock Performance

as on June 2, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹6,450.50
    ₹6,552.00
    downward going graph

    1.26%

    Downside

    0.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹5,636.50
    ₹7,071.50
    downward going graph

    13.72%

    Downside

    8.24%

    Upside

    downward going graph

Divis Laboratories share price movements today

Previous Close
₹6,553.50
Open
₹6,510.00
Volume
3.63L
Upper Circuit
₹7,208.50
Lower Circuit
₹5,898.50
Day's Low - High
₹6,450.50 - ₹6,552.00
52 Week Low - High
₹5,636.50 - ₹7,071.50

Divis Laboratories Historical Returns

1 Month Return
-1 %
3 Month Return
+ 2.34 %
1 Year Return
+ 0.22 %
3 Year Return
+ 86.62 %
5 Year Return
+ 55.51 %

Divis Laboratories Fundamentals

as on June 2, 2026 at 4:01 pm IST

Market Cap

₹1,73,974.83 Cr

Return on Equity (ROE)

15.57

PE Ratio (TTM)

67.74

Return on capital employed (ROCE)

20.63

Industry PE ratio

45.43

Beta (LTM)

0.59

P/B Ratio

10.27

Dividend Yield

0.52

PEG Ratio

4.76

Quarterly Earnings Growth YOY

13.44

EPS (TTM)

82.68

Book Value

564.87

Divis Laboratories Stock Valuation

as on June 2, 2026 at 4:01 pm IST

Divis Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (28.97x)

November 21, 2022

Industry (45.43x)

June 1, 2026

Today (67.74x)

June 1, 2026

Highest (90.48x)

December 4, 2024

LowHigh

Today’s Price to Earnings Ratio: 67.74x

Divis Laboratories Technical Analysis

Track how Divis Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish7
Bullish5
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-1.41
Bearish
CCI (20)
-253
Bullish
RSI (14)
42.63
Neutral
Momentum (10)
-11.5
Bearish
ADI (14)
17.4
Neutral
Ultimate Oscillator (7,14,28)
61.16
Neutral

Moving Averages

Name

Value

Action

SMA (20)
6532.12
Bearish
EMA (20)
6529.73
Bearish
VWMA (20)
6529.23
Bearish
SMA (50)
6526.99
Bearish
EMA (50)
6525.21
Bearish
SMA (200)
6483.16
Bullish
EMA (200)
6500.21
Bullish
KAMA (200)
6520.57
Bullish
DEMA (200)
6506.74
Bullish

Divis Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Divis Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
HOLD1,73,974.8311.1%0.502,1919,360
BUY1,47,237.3042.26%0.661,91111,516
BUY68,993.941.94%0.781,42915,261
BUY37,768.76-5.49%0.536985,616
BUY1,12,308.519.13%0.515,29127,547

Market expectation of Divis Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

48.15%

Buy

18.52%

Hold

33.33%

Sell

Divis Laboratories Stock’s Investor Sentiment and Interest

Search interest for Divis Laboratories Ltd Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Divis Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
1,778
1,909
1,855
2,303
2,118
2,338
2,319
2,585
2,410
2,715
2,604
2,831
Other Income
81
86
95
79
79
106
82
86
119
145
88
155
Total Income
1,859
1,995
1,950
2,382
2,197
2,444
2,401
2,671
2,529
2,860
2,692
2,986
Expenses
1,274
1,430
1,366
1,572
1,496
1,622
1,576
1,699
1,681
1,827
1,788
1,897
Operating Profit
504
479
489
731
622
716
743
886
729
888
816
934
Operating Profit Margin %
28.35%
25.09%
26.36%
31.74%
29.37%
30.62%
32.04%
34.27%
30.25%
32.71%
31.34%
32.99%
Profit Before Interest, Tax and Depreciation
585
565
584
810
701
822
825
972
848
1,033
904
1,089
Interest
-
1
-
2
-
1
-
1
3
8
6
6
Depreciation
93
95
95
95
97
99
99
107
112
113
118
120
Profit Before Tax
492
469
489
713
604
722
726
864
733
912
780
963
Tax Paid
136
121
131
175
174
212
137
202
188
223
197
212
Profit After Tax
356
348
358
538
430
510
589
662
545
689
583
751
Total Net profit including share of profit / Loss from associate company
356
348
358
538
430
510
589
662
545
689
583
751
EPS
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
Actual EPS
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
Adjusted EPS
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31
Diluted EPS
13.41
13.11
13.5
20.25
16.2
19.2
22.2
24.93
20.49
25.97
21.98
28.31

Divis Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
3,912.78
4,946.26
5,394.42
6,969.4
8,959.83
7,767
7,845
9,360
10,560
Other Income
113.44
155.63
189.63
62.56
113.87
345
339
352
507
Total Income
4,026.22
5,101.89
5,584.05
7,031.96
9,073.7
8,112
8,184
9,712
11,067
Expenses
2,651.07
3,074.42
3,572.25
4,109.46
5,077.89
5,399
5,640
6,392
7,193
Operating Profit
1,261.71
1,871.84
1,822.17
2,859.94
3,881.94
2,368
2,205
2,968
3,367
Operating Profit Margin %
32.25%
37.84%
33.78%
41.04%
43.33%
30.49%
28.11%
31.71%
31.88%
Profit Before Interest, Tax and Depreciation
1,375.15
2,027.47
2,011.8
2,922.5
3,995.81
2,713
2,544
3,320
3,874
Interest
1.33
3.5
6.1
0.87
0.8
1
3
2
23
Depreciation
142.49
168.9
186.24
255.59
311.51
343
378
402
463
Profit Before Tax
1,231.33
1,855.07
1,819.46
2,666.04
3,683.5
2,369
2,163
2,916
3,388
Tax Paid
354.32
502.33
442.92
681.75
723.05
545
563
725
820
Profit After Tax
877.01
1,352.74
1,376.54
1,984.29
2,960.45
1,824
1,600
2,191
2,568
Total Net profit including share of profit / Loss from associate company
877.01
1,352.74
1,376.54
1,984.29
2,960.45
1,824
1,600
2,191
2,568
EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75
Actual EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75
Adjusted EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75
Diluted EPS
33.04
50.96
51.85
74.75
111.52
68.69
60.27
82.53
96.75

Divis Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,037.86
1,150.37
775.86
954.3
1,215.94
1,946.93
1,911.8
2,459.73
1,261
1,653
Cash Flow from Investing Activities
-406.41
-1,139.6
-478.3
-685.4
-83.47
75.13
-2,194.92
-2,707.62
-269
-804
Cash Flow from Financing Activities
-631.12
2.38
-314.16
-245.94
-1,091.42
-34.89
-532.44
-797.17
-799
-799
Net Cash Flow
0.33
13.15
-16.6
22.96
41.05
1,987.17
-815.56
-1,045.06
193
50

Divis Laboratories Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
51.93%
51.92%
51.92%
51.9%
51.89%
51.89%
51.89%
51.89%
51.89%
51.88%
51.88%
DII
20.97%
21.88%
22.21%
21.77%
21.06%
20.54%
20.71%
19.05%
19.76%
19.28%
19.22%
FII
0%
14.86%
14.68%
16.16%
17.25%
17.99%
18.01%
19.74%
19.39%
20.08%
20.29%
Public
11.72%
11.33%
11.19%
10.18%
9.8%
9.59%
9.39%
9.32%
8.96%
8.76%
8.6%
Total Outstanding Shares
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
26,54,68,580
Total Shareholders
3,73,860
3,54,482
3,47,629
2,98,310
2,78,899
2,80,601
2,67,755
2,59,825
2,49,634
2,33,844
2,28,006

Mutual Funds that own Divis Laboratories Stock

Check out the Mutual Funds with significant holdings in Divis Laboratories.

Divis Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Divis Laboratories.

  • Divis Laboratories Ltd Earnings Results

    Divis Laboratories Ltd’s net profit jumped 13.44% since last year same period to ₹751.00Cr in the Q4 2025-2026. On a quarterly growth basis, Divis Laboratories Ltd has generated 28.82% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Divis Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Divis Laboratories Ltd has declared dividend of ₹30.00 per share on 17 May 2025 - translating a dividend yield of 0.92%.

    Read More about Dividends

Indices Featuring Divis Laboratories Stock

Check stock indices that include Divis Laboratories.

Nifty Healthcare

₹15,188.20

-0.52 (79.00%)

BSE 200

₹10,972.65

0.41 (44.84%)

BSE Healthcare

₹46,285.06

-0.38 (178.42%)

Nifty Next 50

₹70,115.80

0.28 (193.95%)

Nifty100 Quality

₹5,555.70

1.11 (60.80%)

Nifty LargeMidcap 250

₹16,167.70

0.29 (46.50%)

S&P BSE 250 LargeMidCap

₹10,444.87

0.42 (43.44%)

BSE 500

₹35,227.64

0.43 (150.02%)

BSE 100

₹24,967.56

0.47 (117.86%)

Nifty 200

₹13,577.00

0.36 (48.65%)

BSE MFG

₹1,074.16

0.24 (2.58%)

NIFTY PHARMA

₹24,006.30

-0.86 (207.95%)

S&P BSE 100 LargeCap TMC

₹8,837.39

0.44 (39.08%)

S&P BSE Dividend Stability

₹1,027.49

0.32 (3.29%)

Nifty 500

₹22,521.10

0.37 (83.15%)

Nifty100 Eq Weig

₹33,776.95

0.41 (138.05%)

S&P BSE SEN. N50

₹83,956.46

0.47 (393.45%)

NIFTY 100

₹24,491.30

0.40 (98.25%)

S&P BSE 100 ESG

₹397.71

0.48 (1.91%)

Insights on Divis Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 583.0 Cr → 751.0 Cr (in ₹), with an average increase of 22.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.69K Cr → 2.98K Cr (in ₹), with an average increase of 9.9% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 20.08% to 20.29% in Mar 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.88% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.1% return, outperforming this stock by 38.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.8% return, outperforming this stock by 58.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, DIVISLAB stock has moved down by -3.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 13.73% to 13.42% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.76% to 8.60% in Mar 2026 quarter

Divis Laboratories Stock Futures & Options Contracts

View the latest movement in Divis Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.

Divis Laboratories Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DIVISLAB 30 Jun ₹6600 Call
June 30, 2026
₹6600
₹144
-13.9
-8.8%
DIVISLAB 30 Jun ₹7000 Call
June 30, 2026
₹7000
₹35.05
-1.6
-4.37%
DIVISLAB 30 Jun ₹6800 Call
June 30, 2026
₹6800
₹72.9
-7.7
-9.55%
DIVISLAB 30 Jun ₹6500 Call
June 30, 2026
₹6500
₹195.6
-15.11
-7.17%

Divis Laboratories Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DIVISLAB 30 Jun Fut
June 30, 2026
-
₹6574
-29.72
-0.45%
DIVISLAB 28 Jul Fut
July 28, 2026
-
₹6594
-9.91
-0.15%
DIVISLAB 25 Aug Fut
August 25, 2026
-
₹6651
15.92
0.24%

About Divis Laboratories Ltd

Divis Laboratories Ltd is a leading Indian pharmaceutical company incorporated in 1990. The company specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical market. Divis Laboratories Ltd operates in three lines of business, APIs, Intermediates, and Contract Research and Manufacturing Services (CRAMS).

Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.

Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.

Revenue: ₹2,831.00Cr as on March 2026 (Q4 FY26)
Net Profit: ₹751.00Cr as on March 2026 (Q4 FY26)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
OrganisationDivis Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEORamesh B V Nimmagadda
E-voting on sharesClick here to vote

FAQs

What is Divis Laboratories share price today?

Divis Laboratories share price today stands at ₹6533 as on at the close of the market. Divis Laboratories share today touched a day high of ₹6552 and a low of ₹6450.5.

What is the 52 week high and 52 week low range for Divis Laboratories share?

Divis Laboratories touched a 52 week high of ₹7071.5 and a 52 week low of ₹5636.5. Divis Laboratories share price today i.e. is closed at ₹6533, which is -7.62% down from its 52 week high and 15.91% up from its 52 week low.

What is Divis Laboratories's market capitalisation today?

Divis Laboratories market capitalisation is ₹1,73,974.83 Cr as on .

How to buy Divis Laboratories shares?

To buy Divis Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for DIVISLAB or Divis Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Divis Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Divis Laboratories trading volume today?

Divis Laboratories trading volume is 3.63L as on . This means that 3.63L shares of Divis Laboratories were bought and sold on the stock market during today's trading session.